NUTRA PHARMA CORP. Increase (Decrease) in Accounts Receivable, Related Parties
NUTRA PHARMA CORP. (NPHC) reported Increase (Decrease) in Accounts Receivable, Related Parties of -$2.82 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivableRelatedParties · last filed 2026-08-19
- NUTRA PHARMA CORP. increase (decrease) in accounts receivable, related parties for the quarter ending 2026-06-30 was -$26.18K.
- NUTRA PHARMA CORP. increase (decrease) in accounts receivable, related parties for the quarter ending 2026-03-31 was $23.36K, a 58.18% increase year-over-year.
- NUTRA PHARMA CORP. increase (decrease) in accounts receivable, related parties for the quarter ending 2025-12-31 was $5.40K.
- NUTRA PHARMA CORP. increase (decrease) in accounts receivable, related parties for the quarter ending 2025-09-30 was $15.33K.
- NUTRA PHARMA CORP. increase (decrease) in accounts receivable, related parties for fiscal 2024 was $5.80K.
| Period end | Increase (Decrease) in Accounts Receivable, Related Parties 3 month | Increase (Decrease) in Accounts Receivable, Related Parties 6 month | Increase (Decrease) in Accounts Receivable, Related Parties 6 month as first filed | Increase (Decrease) in Accounts Receivable, Related Parties 9 month | Increase (Decrease) in Accounts Receivable, Related Parties 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$26.18K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-19 | -$2.82K 10-Q · filed 2026-08-19 | $2.58K derived: sum of 3 quarters · filed 2026-08-19 | $17.91K derived: sum of 4 quarters · filed 2026-08-19 | |
| 2026-03-31 | $23.36K 10-Q · filed 2026-05-29 | $28.76K derived: sum of 2 quarters · filed 2026-05-29 | $44.09K derived: sum of 3 quarters · filed 2026-05-29 | $32.98K derived: sum of 4 quarters · filed 2026-08-19 | |
| 2025-12-31 | $5.40K derived: 10-Q 12 month − 10-Q 9 month · filed 2026-05-29 | $20.73K derived: sum of 2 quarters · filed 2026-05-29 | $9.62K derived: sum of 3 quarters · filed 2026-08-19 | $24.39K 10-Q · filed 2026-05-29 | |
| 2025-09-30 | $15.33K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-04-06 | $4.22K derived: sum of 2 quarters · filed 2026-08-19 | $18.98K 10-Q · filed 2026-04-06 | ||
| 2025-06-30 | -$11.11K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-19 | $3.65K 10-Q · filed 2026-08-19 | $9.46K 10-Q · filed 2026-03-25 | ||
| 2025-03-31 | $14.77K 10-Q · filed 2026-03-11 | ||||
| 2024-12-31 | $5.80K 10-K · filed 2026-05-20 |